IRIS
MONTORSI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.233
NA - Nord America 6.577
AS - Asia 1.038
AF - Africa 128
OC - Oceania 66
SA - Sud America 55
Continente sconosciuto - Info sul continente non disponibili 10
Totale 15.107
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.456
SE - Svezia 4.376
IT - Italia 1.308
FI - Finlandia 483
IE - Irlanda 316
IN - India 276
DE - Germania 245
CN - Cina 214
ID - Indonesia 117
GB - Regno Unito 96
SG - Singapore 90
NL - Olanda 80
JP - Giappone 73
CA - Canada 70
IR - Iran 60
FR - Francia 57
AU - Australia 52
TR - Turchia 48
ES - Italia 43
MX - Messico 41
RU - Federazione Russa 41
NG - Nigeria 40
UA - Ucraina 39
BR - Brasile 38
HK - Hong Kong 29
PL - Polonia 24
TW - Taiwan 20
EG - Egitto 19
BE - Belgio 17
CH - Svizzera 16
GR - Grecia 15
IL - Israele 13
PH - Filippine 12
PK - Pakistan 12
VN - Vietnam 12
DZ - Algeria 11
TZ - Tanzania 11
CZ - Repubblica Ceca 10
TN - Tunisia 10
EU - Europa 9
IQ - Iraq 9
KR - Corea 9
NO - Norvegia 9
NZ - Nuova Zelanda 9
GH - Ghana 8
TH - Thailandia 8
AT - Austria 7
BG - Bulgaria 7
CO - Colombia 7
MY - Malesia 7
PT - Portogallo 7
SA - Arabia Saudita 7
BD - Bangladesh 6
HR - Croazia 6
LT - Lituania 6
CM - Camerun 5
HU - Ungheria 5
KE - Kenya 5
PG - Papua Nuova Guinea 5
LK - Sri Lanka 4
MW - Malawi 4
NP - Nepal 4
PA - Panama 4
RO - Romania 4
CL - Cile 3
GN - Guinea 3
MK - Macedonia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CU - Cuba 2
GM - Gambi 2
JM - Giamaica 2
LR - Liberia 2
LU - Lussemburgo 2
LV - Lettonia 2
RE - Reunion 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
ZM - Zambia 2
AL - Albania 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
DK - Danimarca 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
LY - Libia 1
MA - Marocco 1
ME - Montenegro 1
MT - Malta 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
UY - Uruguay 1
Totale 15.107
Salva come PNG Salva come JPEG
Città #
Lawrence 2.114
Princeton 2.107
Ashburn 541
Helsinki 476
New York 422
Milan 354
Dublin 312
Shanghai 189
Pune 154
Rome 83
Seattle 72
Washington 63
Los Angeles 62
Hanover 43
Borås 39
Turin 31
Paris 24
Florence 23
Bengaluru 21
Delhi 21
Sydney 21
Bologna 20
Central 20
Istanbul 20
Pekanbaru 18
London 17
Makassar 17
Palermo 17
Jakarta 16
Mumbai 16
Oldenburg 16
Amsterdam 15
Naples 15
Genoa 14
Council Bluffs 13
Lagos 13
Moscow 13
Redwood City 13
Singapore 13
Bari 12
Boardman 12
Pescara 12
Dar es Salaam 11
Rockville 11
Abuja 10
Chennai 10
Ho Chi Minh City 10
Perugia 10
St Petersburg 10
Tel Aviv 10
Vaprio d'Adda 10
Coslada 9
Hyderabad 9
Iztapalapa 9
Monterrey 9
Padova 9
San Jose 9
Tehran 9
Tokyo 9
Toronto 9
Accra 8
Brisbane 8
Mountain View 8
Perth 8
Prague 8
West Jordan 8
Andover 7
Ankara 7
Athens 7
Berlin 7
Bursa 7
Cairo 7
Corinth 7
Kaohsiung City 7
Kebumen Satu 7
Melbourne 7
Montreal 7
Naaldwijk 7
Nuremberg 7
Pavia 7
Santa Maria 7
Bangkok 6
Barcelona 6
Castel Gandolfo 6
Dalmine 6
Frankfurt am Main 6
Fukushima 6
Guadalajara 6
Isfahan 6
Kish 6
Kolkata 6
Monza 6
Rimini 6
Segrate 6
São Paulo 6
Torino 6
Treviso 6
Uberaba 6
Vienna 6
Zurich 6
Totale 7.934
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 442
Benign Prostatic Hyperplasia and Its Aetiologies 311
Women's sexual dysfunction: a pathophysiological review 228
Organic vs. Psychogenic? The Manichean Diagnosis in Sexual Medicine 67
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study 67
FATTORI PREDITTIVI DI LINFORREA DOPO PROSTATECTOMIA RADICALE E LINFOADENECTOMIA PELVICA 45
Long-term safety and tolerability of thdalafil in the treatment of erectile dysfunction 43
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 43
Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. 41
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 39
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum 37
Worldwide Temporal Trends in Penile Length: A Systematic Review and Meta-Analysis 36
A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation 34
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 31
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 31
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 31
Sildenafil taken at bedtime significantly increases nocturnal erections: Results of a placebo-controlled study 30
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 28
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 28
Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients 27
Nasal congestion after visual sexual stimulation with and without sildenafil (Viagra (R)): a randomized placebo-controlled study 27
A comparative review of apomorphine formulations for erectile dysfunction - Recommendations for use in the elderly 27
Pelvic lymph node dissection in prostate cancer 27
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient 27
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 26
Effect of yohimbine-trazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study. 26
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 26
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 26
Rates and predictors of postoperative complications after Holmium laser enucleation of the prostate (HoLEP) at a high-volume center 26
Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study 25
QUALI SONO I PAZIENTI A RISCHIO DI RECIDIVA BIOCHIMICA DI CARCINOMA PROSTATICO OLTRE I 10 ANNI DI FOLLOW-UP DOPO PROSTATECTOMIA RADICALE? 25
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 24
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 24
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 24
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 24
Second international conference on management of erectile dysfunction: New perspectives on treatment 24
PRESENTAZIONE CLINICA DELLA INDURATIO PENIS PLASTICA NEI PAZIENTI AL DI SOTTO DEI 40 ANNI 24
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 23
Prediction of Sexual Function After Radical Prostatectomy 23
When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool 23
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 23
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 23
How to Select the Optimal Candidates for Renal Mass Biopsy 23
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 22
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 22
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 22
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 22
Biopsy Core Number Represents One of Foremost Predictors of Clinically Significant Gleason Sum Upgrading in Patients With Low-risk Prostate Cancer 22
Infertility as a Proxy of Men's Health: Still a long way to go 22
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 22
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases 21
Testosterone in males with COVID-19: A twelve-month cohort study 21
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores 21
Radical prostatectomy for incidental (stage t1a-t1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence 21
Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization 21
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 21
Leiomyoadenomatoid tumours of the epididymis: A new case report and review of the literature 21
Risk of health status worsening in primary infertile men: A prospective 10-year follow-up study 21
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 21
A Plea for Economically Sustainable Evidence-based Guidelines 21
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer 20
TRANSRECTAL MICROWAVE HYPERTHERMIA FOR ADVANCED PROSTATE-CANCER - LONG-TERM CLINICAL-RESULTS 20
Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature Ejaculation 20
Choosing the Best Candidates for Penile Rehabilitation after Bilateral Nerve-Sparing Radical Prostatectomy 20
A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation 20
L'INVASIONE ESCLUSIVA DEL COLLO VESCICALE DA CARCINOMA PROSTATICO NON DOVREBBE ESSERE CONSIDERATA COME STADIO PT4 20
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 20
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 20
Severely low testosterone in males with COVID-19: a case-control study 20
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 20
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 20
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 20
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 19
The Evolution of Staging of Lymph Node Metastases in Clinically Localized Prostate Cancer 19
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 19
ELETTROSTIMOLAZIONE INTRAOPERATORIA DEI NERVI CAVERNOSI CON ELETTRODI IMPIANTABILI 19
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 19
Safety and Early Oncologic Outcomes of Lung Resection in Patients with Isolated Pulmonary Recurrent Prostate Cancer: A Single-center Experience 19
ADC in the evaluation of side-specific extracapsular extension of prostate cancer: development and internal validation of a nomogram of clinical utility 19
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study 19
Re: Hung-Ming Lam, Holly M. Nguyen, Mark P. Labrecque, et al. Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts. Eur Urol 2020;77:144–55 19
Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy 19
Erectile function after focal therapy for localized prostate cancer: a systematic review 19
Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma 19
Can We Rely Solely on the International Prostate Symptoms Score to Investigate Storage Symptoms in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement? Findings from a Cross-sectional Study 19
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? 19
Infertile couples still undergo assisted reproductive treatments without initial andrological evaluation in the real-life setting: A failure to adhere to guidelines? 19
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 19
Topical prilocaine-lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: results from a prospective randomized trial 18
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 18
PICCOLE MASSE RENALI: SORVEGLIANZA ATTIVA VS. NEFRECTOMIA 18
Clinical Profile of Young Patients with Erectile Dysfunction: Preliminary Findings of a Real-life Cross-sectional Study 18
A risk calculator predicting recurrence in lymph node metastatic penile cancer 18
RE: Penile Prosthesis Insertion in the Era of Antibiotic Stewardship-Are Postoperative Antibiotics Necessary? 18
Infertile Men Have Higher Prostate-specific Antigen Values than Fertile Individuals of Comparable Age 18
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 18
Normal sperm parameters per se do not reliably account for fertility: A case–control study in the real-life setting 18
Endoplasmic reticulum oxidoreductase 1 alpha modulates prostate cancer hallmarks 18
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 18
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 18
Totale 3.333
Salva come PNG Salva come JPEG
Categoria #
all - tutte 317.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 317.343
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 0 4
2019/2020137 73 3 2 9 39 0 0 1 7 3 0 0
2020/2021174 0 0 11 3 2 124 8 2 8 6 8 2
2021/20221.270 1 57 30 577 61 63 90 75 42 69 55 150
2022/202310.100 4.860 1.735 598 119 68 1.009 434 605 272 96 149 155
2023/20243.909 233 279 399 356 413 922 292 508 90 381 36 0
Totale 16.032